Prevention of host-to-host transmission by SARS-CoV-2 vaccines

As the number of individuals vaccinated against SARS-CoV-2 rises worldwide, population-level data regarding the vaccines' ability to reduce infection are being generated. Randomised trials have shown that these vaccines dramatically reduce symptomatic COVID-19; however, less is known about thei...

Descripción completa

Detalles Bibliográficos
Autores principales: Mostaghimi, Darius, Valdez, Caroline N, Larson, Haleigh T, Kalinich, Chaney C, Iwasaki, Akiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Personal View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439617/
https://www.ncbi.nlm.nih.gov/pubmed/34534512
http://dx.doi.org/10.1016/S1473-3099(21)00472-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439617/
https://www.ncbi.nlm.nih.gov/pubmed/34534512
http://dx.doi.org/10.1016/S1473-3099(21)00472-2

Ejemplares similares